Related Experiment Video

Updated: Jun 29, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 18, 2014

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

R K Ernst1, E C Yi, L Guo

  • 1Department of Medicine, University of Washington, Seattle, WA 98195, USA.

Science (New York, N.Y.)
|November 24, 1999
PubMed

Insights

Cystic fibrosis (CF) patients have Pseudomonas aeruginosa (PA) infections. PA in CF airways produces specific lipopolysaccharide (LPS) lipid A structures linked to antimicrobial resistance and inflammation, contributing to airway disease.

Area of Science:

  • Microbiology
  • Immunology
  • Pulmonary Medicine

Background:

  • Cystic fibrosis (CF) is characterized by chronic airway infections, primarily with Pseudomonas aeruginosa (PA).
  • Pseudomonas aeruginosa exhibits metabolic flexibility, altering its cell surface components, including lipopolysaccharide (LPS), in response to environmental cues.
  • The specific lipid A structures of LPS in PA infecting CF airways have not been fully elucidated.

Purpose of the Study:

  • To investigate the diversity of lipid A structures synthesized by Pseudomonas aeruginosa in cystic fibrosis airways.
  • To determine if specific lipid A structures are uniquely produced in the CF lung environment.
  • To assess the functional implications of CF-associated lipid A structures regarding antimicrobial peptide resistance and host inflammatory responses.

Main Methods:

  • Analysis of lipopolysaccharide (LPS) lipid A structures from Pseudomonas aeruginosa isolates obtained from cystic fibrosis patients.
  • Characterization of lipid A modifications, including acylation patterns and the presence of specific moieties like aminoarabinose.
  • In vitro assays to evaluate the susceptibility of PA with specific lipid A structures to cationic antimicrobial peptides.
  • Assessment of inflammatory cytokine production in response to PA expressing distinct CF-specific lipid A structures.

Main Results:

  • Pseudomonas aeruginosa isolated from CF patients synthesized a distinct repertoire of penta- and hexa-acylated lipid A structures.
  • CF-specific lipid A variants were identified, notably those containing palmitate and aminoarabinose.
  • These CF-specific lipid A structures conferred increased resistance to cationic antimicrobial peptides.
  • PA expressing CF-specific lipid A induced heightened inflammatory responses compared to controls.

Conclusions:

  • Pseudomonas aeruginosa adapts its lipopolysaccharide lipid A structure within the unique environment of the cystic fibrosis airway.
  • CF-specific lipid A structures, characterized by palmitate and aminoarabinose, contribute to immune evasion by resisting antimicrobial peptides.
  • These modified LPS structures are implicated in exacerbating airway inflammation and driving pathogenesis in cystic fibrosis lung disease.

More Related Videos

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Phylum Actinobacteria01:30

Bacterial Phylum Actinobacteria

Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...